• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIN Jie,WANG Feng,LIU Weijing,WANG Liqing,ZOU Liyi.Clinical medication analysis and pharmaceutical care of a case of colon cancer with venous thrombosis[J].Journal Of Pharmaceutical Research,2023,42(4):275-280[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2505times   Download 2640次 QR Code for this article
Scan with your phone!
1例结肠癌合并静脉血栓病例临床用药分析和药学监护
林杰1,王烽2,刘伟菁1,王黎青3,邹丽宜1
Font:Larger+|Default|Smaller-
(1.广东医科大学药学院,广东 东莞 523808;2.广东医科大学药学院,广东 湛江 524023;3.中山大学附属第七医院药学部,广东 深圳 518107)
摘要:
目的 探讨临床药师在结肠癌合并静脉血栓患者治疗过程中发挥的个体化药学服务作用。方法 临床药师通过临床药学查房、详细的药学问诊、会诊、查阅文献和交流讨论等,参与患者抗凝治疗,抗感染治疗,对低分子肝素(LMWH)在围手术期的使用以及术后出血的原因进行分析,提出处理意见,对患者进行用药教育。结果 对结肠癌合并静脉血栓患者的治疗以及围手术期的处理应该权衡利弊进行个体化管理,同时警惕低分子肝素导致的出血性不良反应。结论 临床药师积极高效参与患者治疗过程,提供个体化药学服务,协助医师制定治疗方案,有利于抗凝药物和抗感染药物的合理、安全使用。
关键词:  结肠癌  静脉血栓  抗凝治疗  低分子肝素  抗菌药物
DOI:10.13506/j.cnki.jpr.2023.04.013
基金项目:
Clinical medication analysis and pharmaceutical care of a case of colon cancer with venous thrombosis
LIN Jie1,WANG Feng2,LIU Weijing1,WANG Liqing3,ZOU Liyi1
(1.The school of Pharmacy ,Guangdong Medical University, Dongguan Guangdong 523808, China;2.The school of Pharmacy ,Guangdong Medical University, Zhanjiang Guangdong 524023, China;3.The department of pharmacy, Seventh Affiliated Hospital of Sun Yat-sen University,Shengzhen Guangdong 518107,China)
Abstract:
Objective To explore the role of clinical pharmacists in the treatment of patient with colon cancer combined with venous thrombosis in individualized pharmaceutical care.Methods Clinical pharmacists participate in patients' anticoagulation treatment through clinical pharmacy rounds, detailed pharmacy consultations, consultations, literature review and exchanges and discussions, etc., and analyze the use of low molecular weight heparin (LMWH) in the perioperative period and the causes of postoperative bleeding, provide treatment suggestions and provide medication education to patients. Results The treatment and perioperative management of patients with colon cancer complicated with venous thrombosis should be individualized, and the bleeding adverse reactions caused by LMWH should be vigilant.Conclusion Clinical pharmacists actively and efficiently participate in the treatment process of patients, provide individualized pharmaceutical services, and assist physicians in formulating treatment plans to facilitate the rational and safe use of anticoagulant drugs.
Key words:  Colon cancer  Venous thrombosis  Anticoagulant therapy  Low molecular weight heparin  Antibacterial drugs
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.